Vallabhaneni, Snigdha
Centers for Disease Control and Prevention · National Center for Emerging and Zoonotic Infectious Diseases
29 papers on CoChatORCID 0000-0003-4149-9840
Most cited papers
- Verified
Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses
Lockhart, S. R., Etienne, K. A., Vallabhaneni, S., Farooqi, J., Chowdhary, A., Govender, N. P., Colombo, A. L., Calvo, B., Cuomo, C. A., Desjardins, C. A., et al. (2017) · Clinical Infectious Diseases
Antifungal resistance and susceptibilityYeasts and Rust Fungi Studies
Cited by 1,662
- Verified
Candida auris : The recent emergence of a multidrug-resistant fungal pathogen
Forsberg, K., Woodworth, K., Walters, M., Berkow, E. L., Jackson, B., Chiller, T., & Vallabhaneni, S. (2019) · Medical Mycology
Antifungal resistance and susceptibilityYeasts and Rust Fungi Studies
Cited by 421
- Verified
Investigation of the First Seven Reported Cases of Candida auris, a Globally Emerging Invasive, Multidrug-Resistant Fungus — United States, May 2013–August 2016
Vallabhaneni, S., Kallen, A., Tsay, S., Chow, N., Welsh, R., Kerins, J., Kemble, S. K., Pacilli, M., Black, S. R., Landon, E., et al. (2016) · MMWR. Morbidity and Mortality Weekly Report
Antifungal resistance and susceptibilityFungal Infections and Studies
Cited by 302
- Verified
The global burden of fungal diseases
Vallabhaneni, S., Mody, R. K., Walker, T., & Chiller, T. (2016) · Infectious Disease Clinics of North America
Fungal Infections and StudiesAntifungal resistance and susceptibility
Cited by 292
- Verified
Multiple introductions and subsequent transmission of multidrug-resistant Candida auris in the USA: a molecular epidemiological survey.
Chow, N. A., Gade, L., Tsay, S. V., Forsberg, K., Greenko, J. A., Southwick, K. L., Barrett, P. M., Kerins, J. L., Lockhart, S. R., Chiller, T. M., et al. (2018) · The Lancet Infectious Diseases
Antifungal resistance and susceptibilityYeasts and Rust Fungi Studies
Cited by 289
- Verified
Candida auris in Healthcare Facilities, New York, USA, 2013–2017
Adams, E., Quinn, M., Tsay, S., Poirot, E., Chaturvedi, S., Southwick, K., Greenko, J., Fernandez, R., Kallen, A., Vallabhaneni, S., et al. (2018) · Emerging Infectious Diseases
Antifungal resistance and susceptibilityInfection Control in Healthcare
Cited by 284
- Verified
Investigation of the First Seven Reported Cases of Candida auris, a Globally Emerging Invasive, Multidrug-Resistant Fungus—United States, May 2013–August 2016
Vallabhaneni, S., Kallen, A., Tsay, S., Chow, N., Welsh, R., Kerins, J., Kemble, S. K., Pacilli, M., Black, S. R., Landon, E., et al. (2017) · American Journal of Transplantation
Antifungal resistance and susceptibilityFungal Infections and Studies
Cited by 247
- Verified
Integrated genomic, epidemiologic investigation of Candida auris skin colonization in a skilled nursing facility
Proctor, D. M., Dangana, T., Sexton, D. J., Fukuda, C., Yelin, R. D., Stanley, M., Bell, P. B., Baskaran, S., Deming, C., Chen, Q., et al. (2021) · Nature Medicine
Antifungal resistance and susceptibilityInfection Control in Healthcare
Cited by 198
- Verified
Population-Based Active Surveillance for Culture-Confirmed Candidemia — Four Sites, United States, 2012–2016
Toda, M., Williams, S. R., Berkow, E. L., Farley, M. M., Harrison, L. H., Bonner, L., Marceaux, K. M., Hollick, R., Zhang, A. Y., Schaffner, W., et al. (2019) · MMWR Surveillance Summaries
Antifungal resistance and susceptibilityYeasts and Rust Fungi Studies
Cited by 198
- Verified
Epidemiology and risk factors for echinocandin nonsusceptible Candida glabrata bloodstream infections: data from a large multisite population-based Candidemia Surveillance Program, 2008–2014
Vallabhaneni, S., Cleveland, A. A., Farley, M. M., Harrison, L. H., Schaffner, W., Beldavs, Z. G., Derado, G., Pham, C. D., Lockhart, S. R., & Smith, R. M. (2015) · Open Forum Infectious Diseases
Antifungal resistance and susceptibilityFungal Plant Pathogen Control
Cited by 187
- Verified
Burden of Candidemia in the United States, 2017
Tsay, S. V., Mu, Y., Williams, S., Epson, E., Nadle, J., Bamberg, W. M., Barter, D. M., Johnston, H. L., Farley, M. M., Harb, S., et al. (2020) · Clinical Infectious Diseases
Antifungal resistance and susceptibilityFungal Infections and Studies
Cited by 163
- Verified
Factors Associated With Candida auris Colonization and Transmission in Skilled Nursing Facilities With Ventilator Units, New York, 2016–2018
Rossow, J., Ostrowsky, B., Adams, E., Greenko, J., McDonald, R., Vallabhaneni, S., Forsberg, K., Perez, S., Lucas, T., Alroy, K. A., et al. (2021) · Clinical Infectious Diseases
Antifungal resistance and susceptibilityInfection Control in Healthcare
Cited by 125
- Verified
Seroadaptive practices: association with HIV acquisition among HIV-negative men who have sex with men.
Vallabhaneni, S., Li, X., Vittinghoff, E., Donnell, D., Pilcher, C. D., & Buchbinder, S. P. (2012) · PLoS ONE
HIV/AIDS Research and InterventionsHIV, Drug Use, Sexual Risk
Cited by 113
- Verified
Regional Emergence of Candida auris in Chicago and Lessons Learned From Intensive Follow-up at 1 Ventilator-Capable Skilled Nursing Facility
Pacilli, M., Kerins, J. L., Clegg, W. J., Walblay, K. A., Adil, H., Kemble, S. K., Xydis, S., McPherson, T. D., Lin, M. Y., Hayden, M. K., et al. (2020) · Clinical Infectious Diseases
Antifungal resistance and susceptibilityInfection Control in Healthcare
Cited by 103
- Verified
Trends in hospitalizations related to invasive aspergillosis and mucormycosis in the United States, 2000–2013
Vallabhaneni, S., Benedict, K., Derado, G., & Mody, R. K. (2017) · Open Forum Infectious Diseases
Antifungal resistance and susceptibilityFungal Infections and Studies
Cited by 98
- Verified
Neonatal and Pediatric Candidemia: Results From Population-Based Active Laboratory Surveillance in Four US Locations, 2009–2015
Benedict, K., Roy, M., Kabbani, S., Anderson, E. J., Farley, M. M., Harb, S., Harrison, L. H., Bonner, L., Wadu, V. L., Marceaux, K., et al. (2018) · Journal of the Pediatric Infectious Diseases Society
Antifungal resistance and susceptibilityNeonatal and Maternal Infections
Cited by 81
- Verified
Neurocognitive consequences of HIV in southern India:A preliminary study of clade C virus
YEPTHOMI, T., PAUL, R., VALLABHANENI, S., KUMARASAMY, N., TATE, D. F., SOLOMON, S., & FLANIGAN, T. (2006) · Journal of the International Neuropsychological Society
HIV Research and TreatmentHIV/AIDS drug development and treatment
Cited by 73
- Verified
Thinking beyond the Common Candida Species: Need for Species-Level Identification of Candida Due to the Emergence of Multidrug-Resistant Candida auris
Lockhart, S. R., Jackson, B. R., Vallabhaneni, S., Ostrosky-Zeichner, L., Pappas, P. G., & Chiller, T. (2017) · Journal of Clinical Microbiology
Antifungal resistance and susceptibilityYeasts and Rust Fungi Studies
Cited by 61
- Verified
The Changing Epidemiology of Candidemia in the United States: Injection Drug Use as an Increasingly Common Risk Factor—Active Surveillance in Selected Sites, United States, 2014–2017
Zhang, A. Y., Shrum, S., Williams, S., Petnic, S., Nadle, J., Johnston, H., Barter, D., Vonbank, B., Bonner, L., Hollick, R., et al. (2020) · Clinical Infectious Diseases
Antifungal resistance and susceptibilityInfective Endocarditis Diagnosis and Management
Cited by 54
- Verified
Trends in antifungal use in US hospitals, 2006–12
Vallabhaneni, S., Baggs, J., Tsay, S., Srinivasan, A. R., Jernigan, J. A., & Jackson, B. R. (2018) · Journal of Antimicrobial Chemotherapy
Antifungal resistance and susceptibilityAntibiotic Use and Resistance
Cited by 45
- Verified
Notes from the Field: Surveillance for Candida auris — Colombia, September 2016–May 2017
Escandón, P., Cáceres, D. H., Espinosa-Bode, A., Rivera, S., Armstrong, P., Vallabhaneni, S., Berkow, E. L., Lockhart, S. R., Chiller, T., Jackson, B. R., et al. (2018) · MMWR. Morbidity and Mortality Weekly Report
Antifungal resistance and susceptibilityYeasts and Rust Fungi Studies
Cited by 42
- Verified
Emerging multidrug-resistant Candida duobushaemulonii infections in Panama hospitals: importance of laboratory surveillance and accurate identification.
Ramos, R., Caceres, D. H., Perez, M., Garcia, N., Castillo, W., Santiago, E., Borace, J., Lockhart, S. R., Berkow, E. L., Hayer, L., et al. (2018) · Journal of Clinical Microbiology
Antifungal resistance and susceptibilityYeasts and Rust Fungi Studies
Cited by 32
- Verified
2039. New York State 2016–2018: Progression from Candida auris Colonization to Bloodstream Infection
Southwick, K., Adams, E. H., Greenko, J., Ostrowsky, B., Fernandez, R., Patel, R., Quinn, M., Vallabhaneni, S., Denis, R. J., Erazo, R., et al. (2018) · Open Forum Infectious Diseases
Antifungal resistance and susceptibilityInfection Control in Healthcare
Cited by 26
- Verified
Candida auris: An Emerging Antimicrobial Resistance Threat
Vallabhaneni, S., Jackson, B. R., & Chiller, T. M. (2019) · Annals of Internal Medicine
Antifungal resistance and susceptibilityYeasts and Rust Fungi Studies
Cited by 25
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free